Universal vaccine to treat colds, flu and COVID developed, and a new study suggests it just might work

Vaccines have traditionally worked by teaching the immune system to recognize a specific virus or bacterium—in effect, ...
PharmiWeb

Bioxytran Initiates Research Collaboration with University of Georgia to Evaluate Drug Candidate's Ability to Block H5N1 Bird Flu Virus

Bioxytran, Inc. (OTCQB: BIXT), a clinical-stage biotechnology company developing breakthrough antiviral treatments, today announced it has initiated a research collaboration with the University of ...
Hoodline

Ohio State Scientists Sound Alarm On Cattle ‘D’ Flu Jumping To Humans

In the new study, Ohio State researchers exposed human lung epithelial cell lines, well-differentiated airway cultures and ...

Bioxytran, Inc.: Bioxytran Initiates Research Collaboration with University of Georgia to Evaluate Drug Candidate's Ability to Block H5N1 Bird Flu Virus

BOSTON, MA / ACCESS Newswire / February 23, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company ...

Merck: Why Investors Should Remain Bullish Despite Patent Risks

Merck started 2026 on a high note. Read why MRK stock is still one of the best choices among Big Pharma players for long-term-oriented investors.
Morning Overview on MSN

Silent flu D may already be spreading in humans. Is a new pandemic next?

Influenza D virus, a pathogen best known for causing respiratory illness in cattle, appears to be silently infecting farmworkers across multiple continents, according to a growing body of serological ...
The Manila Times

Cocrystal Pharma’s First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026

CDI‑988 is the first oral antiviral drug candidate being developed for prevention and treatment of norovirus ...
Morning Overview on MSN

Giant viruses may be far more alive than anyone imagined

For decades, biology textbooks have drawn a firm line: viruses are not alive. They lack the machinery to reproduce on their own, they carry no metabolism, and they depend entirely on host cells to ...
Frontiers

Recombinant serralysin metalloproteases D enhances the intracellular replication of infectious bovine rhinotracheitis virus

1 Key Laboratory of Animal Disease and Human Health of Sichuan Province, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, China 2 State Key Laboratory of Virology, ...
Pharmabiz

DIFF Biotech’s nasal spray influenza vaccine, DIFF-flu receives China NMPA approval

DIFF Biotech’s nasal spray influenza vaccine, DIFF-flu receives China NMPA approval: Hangzhou, China Wednesday, February 11, 2026, 15:00 Hrs [IST] Zhejiang Difference Biological ...
The Manila Times

DIFF Biotech's Innovative Nasal Spray Influenza Vaccine Receives Clinical Trial Approval, Introducing a New Attenuation Pathway

Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval ...